Verified· 2 sources

Synthena AG

Summary

About the company

The company develops oligonucleotide-based medicines on a chemical and pharmaceutical basis, primarily for the treatment of rare, genetic diseases such as muscular dystrophy, using a unique molecular platform that is continuously improved and developed. The company can commercialize its expertise itself or grant licenses to third parties. The company can invest in other ventures or collaborate with them and engage in all activities that promote and are related to the company's purpose.

Commercial register, canton of BE·As of March 31, 2021View on Zefix

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Synthena AG

About the company

Synthena AG in comparison

Industry comparisons are coming soon

Looking for direct email addresses and phone numbers?

Synthena AG

About the company

Synthena AG in comparison

Industry comparisons are coming soon

Looking for direct email addresses and phone numbers?

Is this your company?

Location

At a glance

No knowledge articles yet

Similar companies